Jagsonpal Pharmaceuticals Limited develops and manufactures active pharmaceutical ingredients (APIs ) and formulations worldwide. The company’s APIs include allylestrenol, dextropropoxyphene HCL, dextropropoxyphene napsylate, disulfiram, thiopental sodium, thiopental acid, tolnaftate, and sildenafil citrate, as well as metformin HCL, BP, USP, and EP. It offers products for various therapeutic categories, such as anabolic steroids, analgesics, anesthetics, anti-allergic, anti-asthamatics, anti-cholinergic agents, anti-convulsants, anti-diabetics, anti-diarrhoeals, anti-emetics, anti-epileptics, anti-fungal agents, anti-gout agents, anti-inflammatory agents, anti-malarials, anti-nauseants, anti-protozoals, anti-pyretic, anti-rheumatic drugs, anti-spasmodic agents, and anti-septic agents. The company also provides anti-tubercular drugs, anti-ulcerants, anxiolytics, cardiovascular drugs, corticosteroids, cough syrups, diuretics, drugs for alcohol dependence, GI anti-infectives, haematinics, imaging agents, laxatives, male/female hormones, multivitamins, nutraceuticals, ophthalmic lubricants, oral rehydrating salts, sedative-hypnotics, softgels, systemic anti-infectives, throat pain spray, tonics, and uterine stimulants. Jagsonpal Pharmaceuticals Limited sells its products under the Lycored, Maintane, Metadec, Metabol, Doxypal DR, Parvon, and Indocap SR brand names. The company was founded in 1964 and is based in New Delhi, India.
T-210 J, Shahpur Jat
New Delhi, 110049
Phone: 91 11 2649 4519
Fax: 91 11 2649 8341www.jagsonpal.com
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content.
|No competitor information is available for JGPH.|
|View Industry Companies|
Sponsored Financial Commentaries
To contact JAGSONPAL PHARMACEUTICALS, please visit www.jagsonpal.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.